Lola Health Review 2026: The Women's GLP-1 Programme Explained

Most GLP-1 clinics treat weight loss as a standalone problem. Lola Health treats it as a problem that, in women, rarely exists in isolation. Weight gain in women is frequently entangled with PCOS, thyroid dysfunction, perimenopause, hormonal fluctuation through the menstrual cycle, insulin resistance, and the long-term metabolic consequences of stress. A clinic that does not ask about these things is working with an incomplete picture.

Lola Health is built on the premise that women's weight loss needs a women-specific framework. This review assesses whether the service delivers on that premise.

What Is Lola Health?

Lola Health is a UK-registered online clinic specialising in GLP-1 medication for women. It was founded specifically to address what its founders identified as a gap in the market: most online prescribers were designed by and for men, with no particular consideration of the hormonal, reproductive, and metabolic complexity of female weight.

The service combines:

• Medical consultation and GLP-1 prescription
• Women's health clinical assessment covering hormones, menstrual health, and thyroid
• Ongoing nurse-led clinical support
• Nutrition coaching from practitioners with women's health expertise
• Integrated guidance on managing GLP-1 treatment alongside hormonal conditions

Lola Health is not simply a prescription-plus-lifestyle service. It is attempting to be a genuinely integrative women's health clinic that happens to prescribe GLP-1 medication.

Who Can Use Lola Health?

Eligibility follows the standard BMI criteria for GLP-1 prescribing:

• BMI 30 or above
• BMI 27 or above with a weight-related condition (PCOS, type 2 diabetes, hypertension, fatty liver disease)
• No contraindications to GLP-1 medications
• Not currently pregnant or breastfeeding

Lola Health's intake process asks additional questions that most other clinics do not. These include:

• Menstrual cycle regularity and any known menstrual disorders
• PCOS diagnosis or suspected symptoms
• Perimenopausal or menopausal status
• Thyroid history
• Hormonal contraception use
• Previous or current eating disorders

These additional questions matter because they shape both the clinical approach and the coaching plan. A woman with PCOS and insulin resistance needs a different nutritional strategy than a woman without it. The intake form is where Lola Health earns its differentiation.

Medications Available

Lola Health prescribes both main GLP-1 medications currently available in the UK:

Wegovy (semaglutide 2.4 mg at therapeutic dose): The standard obesity-licensed semaglutide product. Once-weekly injection via auto-injector pen. Licensed for chronic weight management in adults with BMI 30+ or 27+ with weight-related comorbidity.

Mounjaro (tirzepatide): The dual GIP/GLP-1 agonist. Currently showing the strongest average weight loss outcomes in clinical trials. Licensed in the UK for both type 2 diabetes and, more recently, weight management.

The prescribing decision is made following the clinical assessment. Lola Health's clinicians report that Mounjaro is increasingly their first-line recommendation for women with insulin resistance, polycystic ovarian syndrome, or a metabolic profile suggesting GIP receptor engagement would be particularly beneficial.

Pricing

Lola Health's pricing reflects the additional clinical and coaching layer in its programme:

| Tier | Approximate monthly cost | |------|--------------------------| | Medication only (Wegovy/Mounjaro at starting dose) | £179/month | | Full programme (medication + coaching) | £199-£249/month | | Therapeutic dose (full programme) | £219-£269/month |

These figures are estimates; exact pricing depends on your clinical assessment and chosen programme tier. The pricing premium over budget services such as Voy is approximately £30-£70 per month at comparable doses. For many women, the question is whether the additional support justifies the additional cost.

The Onboarding Process

Lola Health's onboarding is more comprehensive than most private GLP-1 services:

Step 1: Women's health intake form. The initial questionnaire takes 20-30 minutes. It covers BMI eligibility, medical history, contraindications, and the additional women's health factors listed above. The depth of questioning is noticeably greater than at generic clinics.

Step 2: Clinical consultation. A video consultation with a nurse practitioner follows. For women with complex hormonal histories (PCOS, perimenopause, thyroid conditions), this consultation typically runs longer than at standard services. The prescriber will discuss your weight history, hormonal context, medication options, and what the programme involves.

Step 3: Blood tests. Lola Health strongly recommends, and in some cases requires, baseline blood tests before prescribing. These may include HbA1c, fasting glucose, thyroid function, full blood count, and ferritin. This is appropriate practice and distinguishes Lola from purely form-based services.

Step 4: Prescription and medication delivery. Medication is dispatched via regulated pharmacy partners. Delivery typically arrives within 3-5 working days.

Step 5: Coaching assignment. Women on the full programme are matched with a health coach with women's health expertise. The coaching relationship is ongoing and covers nutrition, exercise, and the psychological dimensions of weight management.

Support Structure

This is where Lola Health genuinely differentiates itself from the volume-based market:

Nurse-led check-ins: Regular consultations at dose escalation points and on an ongoing schedule. These are substantive appointments, not quick sign-offs.

Messaging support: Clinical messaging to a nurse is available between consultations, with response times that are generally faster than at high-volume clinics.

Women's health coaching: Coaches provide nutritional guidance tailored to hormonal context. If you're perimenopausal, the nutritional conversation is different. If you have PCOS with insulin resistance, the carbohydrate and fibre strategy is different. This specificity is where the coaching adds real value.

Educational content: Lola Health's in-app content library covers GLP-1 treatment alongside women's health topics including PCOS, perimenopause, thyroid health, and hormonal fertility.

Lola Health and PCOS

For women with PCOS, GLP-1 treatment has specific clinical relevance beyond weight loss. Semaglutide and tirzepatide improve insulin sensitivity, which addresses one of the core metabolic drivers of PCOS. They have been shown in observational and early trial data to improve cycle regularity, reduce androgen levels, and in some cases improve ovulation frequency.

Lola Health's clinical team understands these mechanisms. The nutritional coaching for PCOS includes guidance on carbohydrate quality, meal timing and insulin response, and micronutrient considerations specific to PCOS. This is the kind of integrated care that women with PCOS rarely get in a single service.

For the full evidence base on GLP-1 for PCOS, see GLP-1 for PCOS UK.

Lola Health and Perimenopause

Perimenopausal weight gain is not simply a calorie problem. The hormonal shift of perimenopause, particularly declining oestrogen and progesterone, drives fat redistribution, increased insulin resistance, and changes in appetite regulation. GLP-1 treatment can be effective in this context, but the framing matters.

Lola Health's clinical team asks about perimenopausal status in intake and tailors the coaching accordingly. If you are considering hormone replacement therapy alongside GLP-1 treatment, this is also something the team can discuss in clinical context, though HRT prescribing itself falls outside what Lola offers.

For the evidence base on GLP-1 and menopause, see GLP-1 and menopause weight loss UK.

Side Effects: Clinical Support When It Matters

The first 4-8 weeks of GLP-1 treatment are the most likely to involve significant GI side effects. Having responsive clinical support during this period makes a meaningful difference. Lola Health's support model, with faster messaging response times and more frequent nurse contact, is well-suited to the early phase.

Women starting any GLP-1 programme should read Wegovy side effects in women UK before their first injection to understand the typical timeline and management strategies.

How Lola Health Compares to Voy

The most direct comparison is with Voy, which is the other market-leading UK online GLP-1 service.

For the complete clinic comparison including all 8 services, see best GLP-1 clinics in the UK 2026.

Blood Tests with Medichecks

If you want to arrive at your Lola Health consultation with comprehensive baseline data, Medichecks provides the most practical private blood testing option in the UK.

Limitations

In the interest of balance:

Price: Lola Health is more expensive than Voy and most competitors. The premium is justified by the additional support and specialist framing, but it is a real consideration.

Not for everyone: The women-specific programme is valuable for women with hormonal complexity. For a woman with uncomplicated obesity and no hormonal factors, the premium over a simpler service is harder to justify.

No HRT prescribing: Lola Health addresses the hormonal context of weight but does not prescribe hormone replacement therapy. If you need HRT assessment, that requires a separate GP or menopause specialist consultation.